Trump's acting attorney general moved to reclassify medical marijuana under federal law Apr 23, 2026 · Cris Tolomia The DOJ order immediately shifts FDA-approved and state-licensed cannabis products to Schedule III, lowering barriers to research and easing tax burdens on cannabis companies Read more »